Search for: "SANDOZ, INC." Results 481 - 500 of 679
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
7 Nov 2014, 9:17 am by Lawrence B. Ebert
Sandoz, wherein there was no stipulation for the purposes of seeking an appeal. [read post]
22 Jan 2010, 1:28 pm
Sandoz, Inc., 566 F.3d 1282, 1288 (Fed. [read post]
27 Mar 2014, 6:07 am by John Elwood
Sandoz, Inc., 13-854, made it into the second round; the case raises the question whether a district court’s fact findings made in the course of patent interpretation should be reviewed de novo or for clear error. [read post]
2 Apr 2011, 11:58 pm
Sandoz, Inc., No. 2010-1338, slip op. at 3 (Fed. [read post]
4 Apr 2013, 1:34 pm by Dennis Crouch
Sandoz, Inc., Civil Action 17 3:11-cv-03080-MLC-LHG (Complaint filed: 26 May 2011). [read post]
26 Jun 2008, 6:31 pm
Matkari, 7 F.3d 1130, 1139 (4th Cir. 1993); Sandoz Pharmaceuticals v. [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]